← Back to Clinical Trials
Recruiting NCT06664112

Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis

Trial Parameters

Condition Delivery Complication
Sponsor Centro di Ricerca Clinica Salentino
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex FEMALE
Min Age 20 Years
Max Age 45 Years
Start Date 2024-09-30
Completion 2025-12-30
Interventions
AIDA Analysis

Brief Summary

Aims: Primary aim is to investigate outcomes of eutocic labor, evaluating intrapartum ultrasound parameters by AIDA method: Angle of progression (AoP), Asynclitism degree (AD), fetal head-symphysis distance (HSD), and midline angle (MLA). Secondary aim is to investigate outcomes of dystocic labor, evaluating intrapartum ultrasound parameters by AIDA method: Angle of progression (AoP), Asynclitism degree (AD), fetal head-symphysis distance (HSD), and midline angle (MLA). Tertiary aim is to investigate of neonatal outcomes of eutocic labor: Apgar scores at 1 min, Apgar scores at 5 min. Quaternary aim is to investigate of neonatal outcomes of dystocic labor: Apgar scores at 1 min, Apgar scores at 5 min.

Eligibility Criteria

Inclusion Criteria: All patients in pregnancy, nulliparae, candidates for spontaneous or induced labor, monitored by intrapartum ultrasound, collecting the ultrasound parameters of the labor progress. 1. pregnants in labor, at first pregnancy 2. gestational age ≥37 weeks of gestation Exclusion Criteria: Multiparas who are candidates for cesarean section, premature labor and patients who do not agree to participate in the study (missing data relevant for the study). Exclusion criteria encompassed: breech, transverse, or oblique presentations; twin pregnancies; abnormal placental implantation; HELLP syndrome; coagulation disorders; uterine hyperstimulation (often referred to as "terrified uterus"); non-reassuring fetal heart rate; thick meconium; and cephalopelvic disproportion. 1. Patients who are candidates for cesarean section. 2. Patients in premature labor. 3. Patients who do not agree to participate in the study. 4. Exclusion criteria encompassed: breech, transverse, or oblique pre

Related Trials